Aller au contenu principal
Profil bibliographique

Romy Olsha

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

38Publications signalées
934Citations signalées
1Affiliations récentes

Les institutions déclarées

Les domaines associés

Influenza Virus Research StudiesRespiratory viral infections researchSARS-CoV-2 and COVID-19 ResearchCOVID-19 epidemiological studiesViral gastroenteritis research and epidemiology

Les publications récentes

Accès ouvert 2026 preprint OpenAlex

2025/26 subclade-specific influenza A and B vaccine effectiveness estimates and discordant laboratory-based indicators of vaccine match or mismatch

Lea Separovic, Samantha E Kaweski, Michelle B. Cox, Yuping Zhan et autres

Abstract Background The 2025/26 influenza season included A(H3N2) subclade K predominance with A(H1N1)pdm09 co-circulation and subsequent prolonged influenza B activity. The Canadian Sentinel Practitioner Surveillance Network reports vaccine effectiveness (VE) in the context of genetic and antigenic relatedness to circulating viruses. Methods …

ca (code pays fourni par la source)

0 citations medRxiv
Accès ouvert 2026 article OpenAlex

Interim 2025/26 LP.8.1 vaccine effectiveness estimates against COVID-19 from the Canadian Sentinel Practitioner Surveillance Network (SPSN): insights into possible impact of influenza and other respiratory virus co-circulation

Danuta M. Skowronski, Yuping Zhan, Samantha E Kaweski, Michelle B. Cox et autres

BACKGROUNDThe Canadian Sentinel Practitioner Surveillance Network routinely undertakes multiplex respiratory virus testing, vaccine effectiveness (VE) estimation by test-negative design (TND), and whole genome sequencing (WGS) of vaccine-targeted viruses.AIMTo estimate 2025/26 LP.8.1 VE against community-based COVID-19, including variant-specific, and explore the impact of …

ca (code pays fourni par la source)

1 citation Eurosurveillance
Accès ouvert 2026 article OpenAlex

Effectiveness of 2024/25 KP.2 Vaccine Against Outpatient COVID‐19 in Canada

Lea Separovic, Suzana Sabaiduc, Yuping Zhan, Samantha E Kaweski et autres

The Canadian Sentinel Practitioner Surveillance Network used the test-negative design to assess KP.2 vaccine effectiveness (VE) against medically attended outpatient COVID-19 between November 2024 and April 2025 among participants ≥ 12 years. Analyses included 5410 controls (19% vaccinated) and 435 COVID-19 cases …

ca (code pays fourni par la source)

3 citations Influenza and Other Respiratory Viruses
Accès ouvert 2026 article OpenAlex

Interim 2025/26 influenza vaccine effectiveness estimates with immuno-epidemiological considerations for A(H3N2) subclade K protection, Canada, January 2026

Lea Separovic, Suzana Sabaiduc, Yuping Zhan, Samantha E Kaweski et autres

In interim 2025/26 analyses, the Canadian Sentinel Practitioner Surveillance Network estimates influenza vaccine reduced the risk of medically-attended acute respiratory illness due to predominant influenza A(H3N2) viruses, including antigenically distinct subclade K, by about 40% relative to unvaccinated individuals. Vaccine effectiveness was …

ca (code pays fourni par la source)

25 citations Eurosurveillance
Accès ouvert 2025 article OpenAlex

Measles vaccine virus mutation following vaccination in a healthy child resulting in a false negative vaccine specific PCR test: Ontario, Canada, 2025

Sarah E. Wilson, Vanessa Zubach, Brendan Lew, Maan Hasso et autres

We report a case of a mild, self-limited rash illness in a child 18 days after measles-mumps-rubella-varicella vaccination. Initial testing with a PCR-based method failed to detect vaccine virus. Sequencing later identified a novel mutation in the probe-binding site of the vaccine …

ca (code pays fourni par la source)

2 citations Eurosurveillance
Accès ouvert 2025 preprint OpenAlex

Effectiveness of 2024/25 KP.2 vaccine against outpatient COVID-19 in Canada

Lea Separovic, Suzana Sabaiduc, Yuping Zhan, Samantha E Kaweski et autres

Abstract Between November 2024 and April 2025, the Canadian Sentinel Practitioner Surveillance Network assessed KP.2 vaccine effectiveness against outpatient COVID-19 by test-negative design. Vaccination protected best during the first two months, reducing risk by two-thirds among vaccinated versus unvaccinated individuals, declining by …

ca, Côte d’Ivoire (code pays fourni par la source)

0 citations medRxiv
Accès ouvert 2025 article OpenAlex

Interim estimates of vaccine effectiveness against influenza A(H1N1)pdm09 and A(H3N2) during a delayed influenza season, Canada, 2024/25

Lea Separovic, Yuping Zhan, Samantha E Kaweski, Suzana Sabaiduc et autres

The Canadian Sentinel Practitioner Surveillance Network (SPSN) reports interim 2024/25 vaccine effectiveness (VE) against acute respiratory illness due to laboratory-confirmed influenza during a delayed season of predominant A(H1N1)pdm09 and lower A(H3N2) co-circulation. Through mid-January, the risk of outpatient illness due to influenza …

ca (code pays fourni par la source)

20 citations Eurosurveillance
Accès ouvert 2024 article OpenAlex

2023/24 mid-season influenza and Omicron XBB.1.5 vaccine effectiveness estimates from the Canadian Sentinel Practitioner Surveillance Network (SPSN)

Danuta M. Skowronski, Yuping Zhan, Samantha E Kaweski, Suzana Sabaiduc et autres

The Canadian Sentinel Practitioner Surveillance Network reports mid-season 2023/24 influenza vaccine effectiveness (VE) of 63% (95% CI: 51-72) against influenza A(H1N1)pdm09, lower for clade 5a.2a.1 (56%; 95% CI: 33-71) than clade 5a.2a (67%; 95% CI: 48-80), and lowest against influenza A(H3N2) (40%; …

ca (code pays fourni par la source)

74 citations Eurosurveillance
Accès ouvert 2023 article OpenAlex

Vaccine effectiveness estimates from an early-season influenza A(H3N2) epidemic, including unique genetic diversity with reassortment, Canada, 2022/23

Danuta M. Skowronski, Erica S.Y. Chuang, Suzana Sabaiduc, Samantha E Kaweski et autres

The Canadian Sentinel Practitioner Surveillance Network estimated vaccine effectiveness (VE) during the unusually early 2022/23 influenza A(H3N2) epidemic. Like vaccine, circulating viruses were clade 3C.2a1b.2a.2, but with genetic diversity affecting haemagglutinin positions 135 and 156, and reassortment such that H156 viruses acquired …

ca (code pays fourni par la source)

46 citations Eurosurveillance
Accès ouvert 2022 article OpenAlex

Monkeypox Virus Detection in Different Clinical Specimen Types

Maan Hasso, Stephen J. Perusini, Alireza Eshaghi, Elaine Tang et autres

A global monkeypox outbreak began in May 2022. Limited data exist on specimen type performance in associated molecular diagnostics. Consequently, a diverse range of specimen sources were collected in the initial weeks of the outbreak in Ontario, Canada. Our clinical evaluation identified …

ca, gb (code pays fourni par la source)

30 citations Emerging infectious diseases
Accès ouvert 2022 article OpenAlex

Influenza vaccine effectiveness against A(H3N2) during the delayed 2021/22 epidemic in Canada

Shin Hye Kim, Erica S.Y. Chuang, Suzana Sabaiduc, Romy Olsha et autres

Influenza virus circulation virtually ceased in Canada during the COVID-19 pandemic, re-emerging with the relaxation of restrictions in spring 2022. Using a test-negative design, the Canadian Sentinel Practitioner Surveillance Network reports 2021/22 vaccine effectiveness of 36% (95% CI: -38 to 71) against …

ca (code pays fourni par la source)

23 citations Eurosurveillance
Accès ouvert 2022 article OpenAlex

Real-Time RT-PCR Allelic Discrimination Assay for Detection of N501Y Mutation in the Spike Protein of SARS-CoV-2 Associated with B.1.1.7 Variant of Concern

Mariana Abdulnoor, Alireza Eshaghi, Stephen J. Perusini, George Broukhanski et autres

During the coronavirus disease 2019 (COVID-19) pandemic, several variants of concern (VOCs) have been detected, for example, B.1.1.7, B.1.351, P.1, and B.1.617.2. The VOCs pose a threat to public health efforts to control the spread of the virus. As such, surveillance and …

ca (code pays fourni par la source)

9 citations Microbiology Spectrum

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.